Calif. Says Insulin Makers, PBMs Overcharge Diabetics

By Nadia Dreid (January 12, 2023, 8:29 PM EST) -- Eli Lilly & Co., Novo Nordisk Inc. and Sanofi make virtually all the nation's insulin and have been working with pharmacy benefit managers to keep the cost of the lifesaving drug steadily climbing to "exorbitant" levels, according to a new lawsuit from the state of California....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!